The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease

被引:62
作者
Lee, Y-C [1 ,2 ]
Yen, A. M-F [1 ]
Tai, J. J. [1 ]
Chang, S-H [1 ]
Lin, J-T [2 ,3 ,4 ]
Chiu, H-M [2 ]
Wang, H-P [2 ]
Wu, M-S [2 ]
Chen, T. H-H [1 ]
机构
[1] Natl Taiwan Univ, Coll Publ Hlth, Div Biostat, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 100, Taiwan
[3] E DA Hosp, Dept Internal Med, Kaohsiung, Taiwan
[4] I Shou Univ, Kaohsiung, Taiwan
关键词
BODY-MASS INDEX; CONCEPTUAL-FRAMEWORK; HELICOBACTER-PYLORI; BARRETTS-ESOPHAGUS; SOJOURN TIME; OBESITY; HISTORY; GERD; INTRAOBSERVER; INTEROBSERVER;
D O I
10.1136/gut.2008.162305
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease (GORD), which remains elusive, was quantified. Methods: The population included 3669 subjects undergoing repeated upper endoscopy. Data were analysed using a three-state Markov model to estimate transition rates (according to the Los Angeles classification) regarding the natural course of the disease. Individual risk score together with the kinetic curve was derived by identifying significant factors responsible for the net force between progression and regression. Results: During three consecutive study periods, 12.2, 14.9 and 17.9% of subjects, respectively, progressed from non-erosive to erosive disease, whereas 42.5, 37.3 and 34.6%, respectively, regressed to the non-erosive stage. The annual transition rate from non-erosive to class A-B disease was 0.151 per person year (95% CI 0.136 to 0.165) and from class A-B to C-D was 0.079 per person year (95% CI 0.063 to 0.094). The regression rate from class A-B to non-erosive disease was 0.481 per person year (95% CI 0.425 to 0.536). Class C-D, however, appeared to be an absorbing state when not properly treated. Being male (relative risk (RR) 4.31; 95% CI 3.22 to 5.75), smoking (RR 1.20; 95% CI 1.03 to 1.39) or having metabolic syndrome (RR 1.75; 95% CI 1.29 to 2.38) independently increased the likelihood of progressing from a non-erosive to an erosive stage of disease and/or lowered the likelihood of disease regression. The short-term use of acid suppressants (RR 0.54; 95% CI 0.39 to 0.75) raised the likelihood of regression from erosive to non-erosive disease. Conclusions: Intraoesophageal damage is a dynamic and migratory process in which the metabolic syndrome is associated with accelerated progression to or attenuated regression from erosive states. These findings have important implications for the design of effective prevention and screening strategies.
引用
收藏
页码:174 / 181
页数:8
相关论文
共 39 条
[1]   Estimation of sojourn time in chronic disease screening without data on interval cases [J].
Chen, THH ;
Kuo, HS ;
Yen, MF ;
Lai, MS ;
Tabar, L ;
Duffy, SW .
BIOMETRICS, 2000, 56 (01) :167-172
[2]   Association of metabolic syndrome with proximal and synchronous colorectal neoplasm [J].
Chiu, Han-Mo ;
Lin, Jaw-Town ;
Shun, Chia-Tung ;
Liang, Jin-Tung ;
Lee, Yi-Chia ;
Huang, Shih-Pei ;
Wu, Ming-Shiang .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (02) :221-229
[3]   Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups [J].
Chung, S. J. ;
Kim, D. ;
Park, M. J. ;
Kim, Y. S. ;
Kim, J. S. ;
Jung, H. C. ;
Song, I. S. .
GUT, 2008, 57 (10) :1360-1365
[4]   Abdominal obesity and body mass index as risk factors for Barrett's esophagus [J].
Corley, Douglas A. ;
Kubo, Al ;
Levin, Theodore R. ;
Block, Gladys ;
Habel, Laurel ;
Zhao, Wei ;
Leighton, Pat ;
Quesenberry, Charles ;
Rumore, Greg J. ;
Buffler, Patricia A. .
GASTROENTEROLOGY, 2007, 133 (01) :34-41
[5]  
Cox D., 1977, The theory of stochastic processes, V134
[6]   Gastroesophageal pressure gradients in gastroesophageal reflux disease: Relations with hiatal hernia, body mass index, and esophageal acid exposure [J].
de Vries, Durk R. ;
Van Herwaarden, Margot A. ;
Smout, Andre J. P. M. ;
Samsom, Melvin .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (06) :1349-1354
[7]   An evidence-based appraisal of reflux disease management - the Genval workshop report [J].
Dent, J ;
Brun, J ;
Fendrick, AM ;
Fennerty, MB ;
Janssens, J ;
Kahrilas, PJ ;
Lauritsen, K ;
Reynolds, JC ;
Shaw, M ;
Talley, NJ .
GUT, 1999, 44 :S1-S16
[8]   ESTIMATION OF MEAN SOJOURN TIME IN BREAST-CANCER SCREENING USING A MARKOV-CHAIN MODEL OF BOTH ENTRY TO AND EXIT FROM THE PRECLINICAL DETECTABLE PHASE [J].
DUFFY, SW ;
CHEN, HH ;
TABAR, L ;
DAY, NE .
STATISTICS IN MEDICINE, 1995, 14 (14) :1531-1543
[9]   Helicobacter pylori infection and chronic gastric acid hyposecretion [J].
ElOmar, EM ;
Oien, K ;
ElNujumi, A ;
Gillen, D ;
Wirz, A ;
Dahill, S ;
Williams, C ;
Ardill, JES ;
McColl, KEL .
GASTROENTEROLOGY, 1997, 113 (01) :15-24
[10]   Distinct phenotypic presentations of gastroesophageal reflux disease: A new view of the natural history [J].
Fass, R .
DIGESTIVE DISEASES, 2004, 22 (02) :100-107